Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases.

Growth and rupture of abdominal aortic aneurysms (AAAs) result from increased collagen turnover. Collagen turnover critically depends on specific collagenases that cleave the triple helical region of fibrillar collagen. As yet, the collagenases responsible for collagen degradation in AAAs have not been identified. Increased type I collagen degradation products confirmed collagen turnover in AAAs (median values: <1, 43, and 108 ng/mg protein in control, growing, and ruptured AAAs, respectively). mRNA and protein analysis identified neutrophil collagenase [matrix metalloproteinase (MMP)-8] and cysteine collagenases cathepsin K, L, and S as the principle collagenases in growing and ruptured AAAs. Except for modestly increased MMP-14 mRNA levels, collagenase expression was similar in growing and ruptured AAAs (anterior-lateral wall). Evaluation of posttranslational regulation of protease activity showed a threefold increase in MMP-8, a fivefold increase in cathepsins K and L, and a 30-fold increase in cathepsin S activation in growing and ruptured AAAs. The presence of the osteoclastic proton pump indicated optimal conditions for extracellular cysteine protease activity. Protease inhibitor mRNA expression was similar in AAAs and controls, but AAA protein levels of cystatin C, the principle cysteine protease inhibitor, were profoundly reduced (>80%). We found indications that this secondary deficiency relates to cystatin C degradation by (neutrophil-derived) proteases.

[1]  R. Pike,et al.  Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. , 1995, Archives of biochemistry and biophysics.

[2]  J. Engler,et al.  Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. , 2001, Cancer research.

[3]  P. Hogendoorn,et al.  Cathepsin K is the principal protease in giant cell tumor of bone. , 2004, The American journal of pathology.

[4]  Janet T. Powell,et al.  Mechanical properties of th aneurysmal aorta , 1992 .

[5]  J. Powell,et al.  Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms. , 1989, Journal of vascular surgery.

[6]  T. Henry,et al.  Extracellular Proteases in Atherosclerosis and Restenosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Delmas,et al.  The Collagenolytic Activity of Cathepsin K Is Unique among Mammalian Proteinases* , 1998, The Journal of Biological Chemistry.

[8]  E. Nanba,et al.  Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. , 2003, International angiology : a journal of the International Union of Angiology.

[9]  M. Karsdal,et al.  The Type I Collagen Fragments ICTP and CTX Reveal Distinct Enzymatic Pathways of Bone Collagen Degradation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  V. Turk,et al.  Kinetics of the pH-induced inactivation of human cathepsin L. , 1993, Biochemistry.

[11]  A. Hollander,et al.  Molecular Interaction and Matrix Assembly , 1998, The Biochemical journal.

[12]  W H Baker,et al.  Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. , 1984, Archives of surgery.

[13]  R. Ménard,et al.  Autocatalytic Processing of Recombinant Human Procathepsin L , 1998, The Journal of Biological Chemistry.

[14]  Hong Sun,et al.  Human neutrophil collagenase expression is C/EBP-dependent during myeloid development. , 2005, Experimental hematology.

[15]  M. Thompson,et al.  Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm , 2005, The British journal of surgery.

[16]  S. Carr,et al.  Autocatalytic Activation of Human Cathepsin K* , 1997, The Journal of Biological Chemistry.

[17]  T. Inahara.  Eversion endarterectomy for aortoiliofemoral occlusive disease. A 16 year experience. , 1979, American journal of surgery.

[18]  D. Brömme,et al.  Human Cathepsin O2, a Matrix Protein-degrading Cysteine Protease Expressed in Osteoclasts , 1996, The Journal of Biological Chemistry.

[19]  Z. Werb,et al.  The Serpin α1-Proteinase Inhibitor Is a Critical Substrate for Gelatinase B/MMP-9 In Vivo , 2000, Cell.

[20]  G. Reddy,et al.  Purification and characterization of collagenolytic property of renal cathepsin L from arthritic rat. , 1992, The International journal of biochemistry.

[21]  R. Berguer,et al.  Elevated Expression of Matrix Metalloproteinase-13 in Abdominal Aortic Aneurysms , 2004, Annals of vascular surgery.

[22]  J. Powell,et al.  Mechanical properties of the aneurysmal aorta , 1993 .

[23]  E. Chavakis,et al.  Cathepsin L is required for endothelial progenitor cell–induced neovascularization , 2005, Nature Medicine.

[24]  M. R. Roach,et al.  The composition and mechanical properties of abdominal aortic aneurysms. , 1994, Journal of vascular surgery.

[25]  P. Delvenne,et al.  Gradient of proteolytic enzymes, their inhibitors and matrix proteins expression in a ruptured abdominal aortic aneurysm , 2004, European journal of clinical investigation.

[26]  D. Brömme,et al.  The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. , 2005, Advanced drug delivery reviews.

[27]  P. Libby,et al.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms. , 1999, The Journal of clinical investigation.

[28]  Robert W. Thompson,et al.  Abdominal aortic aneurysms: basic mechanisms and clinical implications. , 2002, Current problems in surgery.

[29]  Janet T. Powell,et al.  Small Abdominal Aortic Aneurysms , 2003 .

[30]  H. Ronday,et al.  Modified proenzymes as artificial substrates for proteolytic enzymes: colorimetric assay of bacterial collagenase and matrix metalloproteinase activity using modified pro-urokinase. , 1997, The Biochemical journal.

[31]  J. Lindholt,et al.  Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms , 2001, The British journal of surgery.

[32]  S. Teitelbaum,et al.  Osteoclastic bone resorption by a polarized vacuolar proton pump. , 1989, Science.

[33]  D. Turk,et al.  Lysosomal cysteine proteases: more than scavengers. , 2000, Biochimica et biophysica acta.

[34]  M. Yamagishi,et al.  Application of real-time RT-PCR to quantifying gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human abdominal aortic aneurysm. , 2004, Atherosclerosis.

[35]  H. Chapman,et al.  Emerging roles for cysteine proteases in human biology. , 1997, Annual review of physiology.

[36]  P. Libby,et al.  Lysosomal Cysteine Proteases in Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[37]  C. Savage,et al.  Can neutrophils be manipulated in vivo? , 2005, Rheumatology.

[38]  D. Fisher,et al.  Pycnodysostosis: role and regulation of cathepsin K in osteoclast function and human disease. , 2002, Current molecular medicine.

[39]  P. Carmeliet.  Proteinases in cardiovascular aneurysms and rupture: targets for therapy? , 2000, The Journal of clinical investigation.

[40]  P. Libby,et al.  Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. , 2006, Atherosclerosis.

[41]  Robert Kleemann,et al.  Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB-C/EBP-β complex formation , 2003 .

[42]  Matthew Bogyo,et al.  Cathepsin V, a Novel and Potent Elastolytic Activity Expressed in Activated Macrophages* , 2004, Journal of Biological Chemistry.

[43]  B. Baxter.  Could medical intervention work for aortic aneurysms? , 2004, American journal of surgery.

[44]  W. Pearce,et al.  Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. , 1997, Surgery.

[45]  R. Busuttil,et al.  Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms. , 1980, Archives of surgery.

[46]  Gorav Ailawadi,et al.  Current concepts in the pathogenesis of abdominal aortic aneurysm. , 2003, Journal of vascular surgery.

[47]  W. Parks.  A confederacy of proteinases. , 2002, The Journal of clinical investigation.

[48]  J. Vassalli,et al.  RNA and protein synthesis in human peripheral blood polymorphonuclear leukocytes , 1979, The Journal of experimental medicine.

[49]  J D Humphrey,et al.  Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. , 2001, Journal of vascular surgery.

[50]  D. J. Hodges,et al.  Collagenase: a key enzyme in collagen turnover. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[51]  G. Ailawadi,et al.  Neutrophil Depletion Inhibits Experimental Abdominal Aortic Aneurysm Formation , 2005, Circulation.